Skip to main content

Branded

  • GSK donates more than $1 million to fight HPV

    LONDON — GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

    GSK announced that it would donate $1 million worth of Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) to the Pink Ribbon Red Ribbon Partnership over the next five years, as well as $50,000 to support the program operations. The partnership is an initiative led by Susan G. Komen for the Cure, UNAIDS, the President's Emergency Relief Plan for AIDS Relief and the George W. Bush Institute.

  • Lilly invests in partnership to fight NCDs

    INDIANAPOLIS — Drug maker Eli Lilly is investing $30 million in a partnership that will address noncommunicable diseases, also known as chronic diseases.

    The Lilly NCD Partnership is committed to fight the rising burden of noncommunicable diseases in developing nations over the next five years, the drug maker said. The first phase of the partnership will focus on improving diabetes care in targeted communities in Brazil, India, Mexico and South Africa.

  • Merck responds to Gardasil criticism

    NEW YORK — Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.

  • Walgreens partners with U.S. health agencies to combat heart disease

    DEERFIELD, Ill. — Walgreens, the Department of Health and Human Services, the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services on Tuesday announced the kick-off of the Million Hearts Initiative, a public and private sector initiative to help prevent 1 million heart attacks and strokes over five years.

  • Barry Manilow joins Sanofi's atrial fibrillation education campaign

    NEW YORK — Singer and atrial fibrillation patient Barry Manilow has joined Sanofi's national education campaign designed to raise awareness about atrial fibrillation.

    The Get Back in Rhythm campaign aims to improve the health and well-being of those affected by the condition by encouraging them to learn more about the risks and talk with their healthcare provider about how to maintain a normal heart rhythm and manage the disease.

  • Study: Sanofi insulin reduces weight gain, increases blood sugar control

    PARIS — An insulin analogue made by Sanofi appears to work better in certain cases than competing treatments at reducing weight gain and controlling blood sugar among patients with Type 2 diabetes.

  • HHS, AT&T partner on mobile diabetes self-management program

    WASHINGTON — The Department of Health and Human Services' Office of Minority Health, the American Association of Diabetes Educators and AT&T on Monday announced an initiative to evaluate the use of mobile devices to deliver diabetes self-management training within an underserved minority community in Dallas.

  • Pharma faces its own hurricane season

    At press time, Hurricane Irene was slowly barreling toward the East Coast and threatening the area with a deluge that prompted cities to shut down and had store shelves wiped clean.


X
This ad will auto-close in 10 seconds